Mastering et al.

A postgrad 'dropout'. An enigmatic genius.
Ground-breaking chemistry waiting to happen.

Quinn Faraday had good intentions when she began a PhD: to discover a new treatment for cancer. Instead, she discovers the snail pace of academia, which has her fearing that all her hard work will amount to nothing.
Amid an existential crisis, she learns of the innovative cancer research that's making waves in industry, as well as the very-nice-to-look-at pioneering scientist behind it all.
Would she really be committing career suicide by withdrawing from her PhD to pursue academia-taboo ways of mastering her chosen research avenue? Only she can make that call.

Dr Caleb Herron's molecular 'trojan horses' have attracted worldwide attention as a revolutionary approach to treating cancer. But his progression towards clinical trials is brought to a standstill (not unlike his love life) when his prototypes fail their latest round of lab tests. At a loss about how to move forward, an idea is presented to him by an aspiring PhD dropout. An idea that's so batsh*t crazy that it might just work.
Could taking a chance on this disarmingly attractive student be the call that changes everything?